Home › Metastatic Cancer › Washington › Spokane Valley
Metastatic Cancer clinical trials in Spokane Valley, WA
4 studies for Metastatic Cancer are looking for participants at sites in and around Spokane Valley (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi away
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi away
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RecruitingObservational study
- Kootenai Clinic Cancer Services Coeur d'Alene, Coeur d'Alene · 21 mi away
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecruitingPhase 3
- Cancer Care Northwest - Vercler, Spokane Valley
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecruitingPhase 3
- Cancer Care Northwest, Spokane Valley
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Spokane Valley
- Non-Small Cell Lung Cancer14 studies
- Prostate Cancer9 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Melanoma6 studies
- Cancer (all types)4 studies
- Bladder Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Colon Cancer4 studies
- Colorectal Cancer4 studies
- Endometrial Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.